Psilocybin could treat depression via a non-hallucinogenic receptor

Psychedelics, psychoactive substances that alter people’s perceptions, mood and thought patterns, have recently shown promise for the treatment of some mental health disorders, including depression and substance use disorders (SUDs). A psychedelic compound that has proved to be particularly promising for the treatment of depression is psilocybin, which is derived from some varieties of hallucinogenic mushrooms.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup